Issue 22, 2021
From the journal:

Physical Chemistry Chemical Physics

Correction: Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2

Ruichao Mao,a   Lihua Bie,a   Maofeng Xu,a   Xiaocong Wang*a  and  Jun Gao*a  

* Corresponding authors

a Hubei Key Laboratory of Agricultural Bioinformatics, College of Informatics, Huazhong Agricultural University, Wuhan, Hubei, China
E-mail: gaojun@mail.hzau.edu.cn

Abstract

Correction for ‘Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2’ by Ruichao Mao et al., Phys. Chem. Chem. Phys., 2021, DOI: 10.1039/d1cp01045j.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D1CP90113C
Article type
Correction
Submitted
21 May 2021
Accepted
21 May 2021
First published
28 May 2021
This article is Open Access
Creative Commons BY license

Phys. Chem. Chem. Phys., 2021,23, 12907-12907

Permissions

Request permissions

Correction: Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2

R. Mao, L. Bie, M. Xu, X. Wang and J. Gao, Phys. Chem. Chem. Phys., 2021, 23, 12907 DOI: 10.1039/D1CP90113C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements